LEAWOOD, Kan., Nov. 28, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats, today announced that it has terminated the offering of shares of its common stock that was announced on Monday, November 27, 2017. The company believes that current market conditions are not conducive for an offering on terms that would be in the best interests of its stockholders.

Aratana Therapeutics logo

Contacts 
For investor inquires:
Craig Tooman
ctooman@aratana.com  
(913) 353-1026

For media inquiries: 
Rachel Reiff
rreiff@aratana.com  
(913) 353-1050

 

View original content with multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-inc-announces-termination-of-offering-of-common-stock-300563255.html

SOURCE Aratana Therapeutics, Inc.

Copyright 2017 PR Newswire

ARATANA THERAPEUTICS, INC. (NASDAQ:PETX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more ARATANA THERAPEUTICS, INC. Charts.
ARATANA THERAPEUTICS, INC. (NASDAQ:PETX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more ARATANA THERAPEUTICS, INC. Charts.